Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial

被引：44
作者：
Russell, Nigel [1 ]
Burnett, Alan [2 ]
Hills, Robert [3 ]
Betteridge, Sophie [3 ]
Dennis, Mike [4 ]
Jovanovic, Jelena [5 ]
Dillon, Richard [5 ]
Grimwade, David [5 ]
机构：
[1] Nottingham Univ Hosp NHS Trust, Ctr Clin Haematol, Nottingham, England
[2] Cardiff Univ, Dept Haematol, Sch Med, Cardiff, S Glam, Wales
[3] Cardiff Univ, Ctr Trials Res, Cardiff, S Glam, Wales
[4] The Christie, Haematol & Transplant Unit, Manchester, Lancs, England
[5] Kings Coll London, Sch Med, Dept Med & Mol Genet, London, England
来源：
BLOOD | 2018年 / 132卷 / 13期
关键词：
ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; CHEMOTHERAPY;
D O I：
10.1182/blood-2018-05-851824
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1452 / 1454
页数：3
相关论文
共 7 条
  • [1] Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab
    Abaza, Yasmin
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Estey, Elihu
    Borthakur, Gautam
    Jabbour, Elias
    Faderl, Stefan
    O'Brien, Susan
    Wierda, William
    Pierce, Sherry
    Brandt, Mark
    Mccue, Deborah
    Luthra, Rajyalakshmi
    Patel, Keyur
    Kornblau, Steven
    Kadia, Tapan
    Daver, Naval
    DiNardo, Courtney
    Jain, Nitin
    Verstovsek, Srdan
    Ferrajoli, Alessandra
    Andreeff, Michael
    Konopleva, Marina
    Estrov, Zeev
    Foudray, Maria
    Mccue, David
    Cortes, Jorge
    Ravandi, Farhad
    [J]. BLOOD, 2017, 129 (10) : 1275 - 1283
  • [2] Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial
    Burnett, A. K.
    Hills, R. K.
    Grimwade, D.
    Jovanovic, J. V.
    Craig, J.
    McMullin, M. F.
    Kell, J.
    Wheatley, K.
    Yin, J. A. L.
    Hunter, A.
    Milligan, D.
    Russell, N. H.
    [J]. LEUKEMIA, 2013, 27 (04) : 843 - 851
  • [3] Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
    Burnett, Alan K.
    Russell, Nigel H.
    Hills, Robert K.
    Bowen, David
    Kell, Jonathan
    Knapper, Steve
    Morgan, Yvonne G.
    Lok, Jennie
    Grech, Angela
    Jones, Gail
    Khwaja, Asim
    Friis, Lone
    McMullin, Mary Frances
    Hunter, Ann
    Clark, Richard E.
    Grimwade, David
    [J]. LANCET ONCOLOGY, 2015, 16 (13) : 1295 - 1305
  • [4] The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
    Kottaridis, PD
    Gale, RE
    Frew, ME
    Harrison, G
    Langabeer, SE
    Belton, AA
    Walker, H
    Wheatley, K
    Bowen, DT
    Burnett, AK
    Goldstone, AH
    Linch, DC
    [J]. BLOOD, 2001, 98 (06) : 1752 - 1759
  • [5] Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
    Lo-Coco, F.
    Avvisati, G.
    Vignetti, M.
    Thiede, C.
    Orlando, S. M.
    Iacobelli, S.
    Ferrara, F.
    Fazi, P.
    Cicconi, L.
    Di Bona, E.
    Specchia, G.
    Sica, S.
    Divona, M.
    Levis, A.
    Fiedler, W.
    Cerqui, E.
    Breccia, M.
    Fioritoni, G.
    Salih, H. R.
    Cazzola, M.
    Melillo, L.
    Carella, A. M.
    Brandts, C. H.
    Morra, E.
    von Lilienfeld-Toal, M.
    Hertenstein, B.
    Wattad, M.
    Luebbert, M.
    Haenel, M.
    Schmitz, N.
    Link, H.
    Kropp, M. G.
    Rambaldi, A.
    La Nasa, G.
    Luppi, M.
    Ciceri, F.
    Finizio, O.
    Venditti, A.
    Fabbiano, F.
    Doehner, K.
    Sauer, M.
    Ganser, A.
    Amadori, S.
    Mandelli, F.
    Doehner, H.
    Ehninger, G.
    Schlenk, R. F.
    Platzbecker, U.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) : 111 - 121
  • [6] Improved OutcomesWith Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
    Platzbecker, Uwe
    Avvisati, Giuseppe
    Cicconi, Laura
    Thiede, Christian
    Paoloni, Francesca
    Vignetti, Marco
    Ferrara, Felicetto
    Divona, Mariadomenica
    Albano, Francesco
    Efficace, Fabio
    Fazi, Paola
    Sborgia, Marco
    Di Bona, Eros
    Breccia, Massimo
    Borlenghi, Erika
    Cairoli, Roberto
    Rambaldi, Alessandro
    Melillo, Lorella
    La Nasa, Giorgio
    Fiedler, Walter
    Brossart, Peter
    Hertenstein, Bernd
    Salih, Helmut R.
    Wattad, Mohammed
    Luebbert, Michael
    Brandts, Christian H.
    Haenel, Mathias
    Roellig, Christoph
    Schmitz, Norbert
    Link, Hartmut
    Frairia, Chiara
    Pogliani, Enrico Maria
    Fozza, Claudio
    D'Arco, Alfonso Maria
    Di Renzo, Nicola
    Cortelezzi, Agostino
    Fabbiano, Francesco
    Doehner, Konstanze
    Ganser, Arnold
    Doehner, Hartmut
    Amadori, Sergio
    Mandelli, Franco
    Ehninger, Gerhard
    Schlenk, Richard F.
    Lo-Coco, Francesco
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06) : 605 - +
  • [7] Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
    Sanz, Miguel A.
    Grimwade, David
    Tallman, Martin S.
    Lowenberg, Bob
    Fenaux, Pierre
    Estey, Elihu H.
    Naoe, Tomoki
    Lengfelder, Eva
    Buechner, Thomas
    Doehner, Hartmut
    Burnett, Alan K.
    Lo-Coco, Francesco
    [J]. BLOOD, 2009, 113 (09) : 1875 - 1891
1